FDA to create training program to inspect more mRNA vaccine manufacturing
With new technology comes the challenges of regulating it. And with the ever-growing faith being poured into mRNA technology the FDA has found itself training new investigators for more inspections going forward.
Investigators will learn about specifics related to Covid-19, influenza, combination and cancer vaccines, as well as the application of testing methods specific to mRNA and the special consideration of contamination control, a recent notice from the FDA says. Training sessions will include on-demand recordings and modules, as well as experiential training through access to a facility or laboratory with medical product manufacturing. Augmented reality and virtual reality will also be included.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.